U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. Office of Prescription Drug Promotion (OPDP) Research
  1. Center for Drug Evaluation and Research (CDER)

Office of Prescription Drug Promotion (OPDP) Research

The Office of Prescription Drug Promotion (OPDP) has an active research program designed to investigate applied and theoretical issues of relevance to direct-to-consumer (DTC) and healthcare provider-directed promotional prescription drug materials. This research program utilizes a number of different research methodologies, including survey and experimental research as well as qualitative research for development purposes. OPDP’s research supports the Food and Drug Administration’s (FDA) goal of science-based policy while maintaining its commitment to protect the public health.  

The OPDP research team also provides technical assistance to outside organizations on the design and implementation of studies concerning prescription drug promotion. Some of these organizations include academic researchers, pharmaceutical companies, and non-profit groups.  For more information on the OPDP research team, please see the team’s brochure.

Contact Us

DTCresearch@fda.hhs.gov

Research Projects and Publications

Access more information about completed research projects, research pending peer review and publication and research in progress.

Return to OPDP Homepage

 

Subscribe to Email Updates

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top